Results for tag: "Ox40 Agonist"

The Ox40 Agonist market is a subset of the oncology drug market, which focuses on treatments for cancer. Ox40 Agonists are a type of immunotherapy drug that works by activating the body’s immune system to fight cancer cells. These drugs are designed to target and activate the Ox40 receptor, which is found on the surface of T cells. This activation helps to increase the number of T cells that can recognize and attack cancer cells. Ox40 Agonists are used in combination with other treatments, such as chemotherapy and radiation, to help improve the effectiveness of cancer treatments. Some companies in the Ox40 Agonist market include AstraZeneca, Bristol-Myers Squibb, Merck, and Pfizer. These companies are actively researching and developing new Ox40 Agonists to improve the effectiveness of cancer treatments. Show Less Read more